•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Dassault Systemes in talks to buy drug trial software firm ArisGlobal, FT reports
Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of June 30, 2026
3DS: Half-year statement of the liquidity contract entered into with Oddo BHF SCA
Dassault Systèmes Announces 16th AAKRUTI Innovation Competition for Students Worldwide, Inspiring Innovations to Solve Global Challenges
Dassault Systèmes successfully issues €1 billion in bonds and refinances its revolving credit facility
Dassault Systèmes Partners with PariSanté Campus to Advance a Sovereign Healthcare Ecosystem in Europe
Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of May 31, 2026
Recursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026?
Dassault Systemes: Downgrade To Hold As The Timing To Growth Acceleration Is Uncertain
Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of April 30, 2026
Combined General Shareholders' Meeting of May 20, 2026: availability of preliminary documents
Dassault Systèmes SE (DASTY) Q1 2026 Earnings Call Transcript
Dassault Systemes reports first-quarter results in line with estimates
Dassault Systèmes reports first quarter 2026 results in line with objectives and confirms full-year outlook
Dassault Systemes (OTCMKTS:DASTY) and Unitronix (OTCMKTS:UTRX) Critical Comparison
Financial Survey: Dassault Systemes (OTCMKTS:DASTY) and SAP (NYSE:SAP)
Dassault Systèmes: Filing of the 2025 Universal Registration Document
Virtus SGA International Growth Q4 2025 Portfolio Activity And Performance
Dassault Systèmes: Amount of the dividend
SAP (NYSE:SAP) & Dassault Systemes (OTCMKTS:DASTY) Head to Head Analysis